429 related articles for article (PubMed ID: 15481985)
21. Testing the sensitivities of noncognate inhibitors to varicella zoster virus thymidine kinase: implications for postherpetic neuralgia therapy with existing agents.
Yang L; Mo X; Yang H; Dai H; Tan F
J Mol Model; 2014 Jul; 20(7):2321. PubMed ID: 24961898
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and in vitro activity of D- and L-enantiomers of 5-(trifluoromethyl)uracil nucleoside derivatives.
Salvetti R; Pregnolato M; Verri A; Focher F; Spadari S; Marchand A; Mathé C; Gosselin G
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1123-5. PubMed ID: 11562969
[TBL] [Abstract][Full Text] [Related]
23. Fluorosubstitution and 7-alkylation as prospective modifications of biologically active 6-aryl derivatives of tricyclic acyclovir and ganciclovir analogues.
Ostrowski T; Golankiewicz B; De Clercq E; Balzarini J
Bioorg Med Chem; 2005 Mar; 13(6):2089-96. PubMed ID: 15727862
[TBL] [Abstract][Full Text] [Related]
24. Influence of 6 or 8-substitution on the antiviral activity of 3-phenethylthiomethylimidazo[1,2-a]pyridine against human cytomegalovirus (HCMV) and varicella-zoster virus (VZV).
Véron JB; Enguehard-Gueiffier C; Snoeck R; Andrei G; De Clercq E; Gueiffier A
Bioorg Med Chem; 2007 Nov; 15(22):7209-19. PubMed ID: 17869124
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antiviral evaluation of cis-substituted cyclohexenyl and cyclohexanyl nucleosides.
Barral K; Courcambeck J; Pèpe G; Balzarini J; Neyts J; De Clercq E; Camplo M
J Med Chem; 2005 Jan; 48(2):450-6. PubMed ID: 15658858
[TBL] [Abstract][Full Text] [Related]
26. Influence of 6- or 8-substitution on the antiviral activity of 3-arylalkylthiomethylimidazo[1,2-a]pyridine against human cytomegalovirus (CMV) and varicella-zoster virus (VZV): part II.
Véron JB; Allouchi H; Enguehard-Gueiffier C; Snoeck R; Andrei G; De Clercq E; Gueiffier A
Bioorg Med Chem; 2008 Nov; 16(21):9536-45. PubMed ID: 18835175
[TBL] [Abstract][Full Text] [Related]
27. (Z)- and (E)-2-(hydroxymethylcyclopropylidene)-methylpurines and pyrimidines as antiviral agents.
Qiu YL; Ptak RG; Breitenbach JM; Lin JS; Cheng YC; Kern ER; Drach JC; Zemlicka J
Antivir Chem Chemother; 1998 Jul; 9(4):341-52. PubMed ID: 9875413
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and ++thiosangivamycin: influence of various 7-substituents on antiviral activity.
Renau TE; Wotring LL; Drach JC; Townsend LB
J Med Chem; 1996 Feb; 39(4):873-80. PubMed ID: 8632411
[TBL] [Abstract][Full Text] [Related]
29. Successful kinase bypass with new acyclovir phosphoramidate prodrugs.
McGuigan C; Derudas M; Bugert JJ; Andrei G; Snoeck R; Balzarini J
Bioorg Med Chem Lett; 2008 Aug; 18(15):4364-7. PubMed ID: 18614365
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and anti-herpes virus activity of 2'-deoxy-4'-thiopyrimidine nucleosides.
Rahim SG; Trivedi N; Bogunovic-Batchelor MV; Hardy GW; Mills G; Selway JW; Snowden W; Littler E; Coe PL; Basnak I; Whale RF; Walker RT
J Med Chem; 1996 Feb; 39(3):789-95. PubMed ID: 8576922
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of novel phosphoramidate ProTides of the 2'-fluoro derivatives of a potent anti-varicella zoster virus bicyclic nucleoside analogue.
Derudas M; Quintiliani M; Brancale A; Andrei G; Snoeck R; Balzarini J; McGuigan C
Antivir Chem Chemother; 2010 Oct; 21(1):15-31. PubMed ID: 21045257
[TBL] [Abstract][Full Text] [Related]
32. Distinct thymidine kinases encoded by cowpox virus and herpes simplex virus contribute significantly to the differential antiviral activity of nucleoside analogs.
Prichard MN; Williams AD; Keith KA; Harden EA; Kern ER
Antiviral Res; 2006 Aug; 71(1):1-6. PubMed ID: 16530858
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy of varicella-zoster virus by a novel class of highly specific anti-VZV bicyclic pyrimidine nucleosides.
Balzarini J; McGuigan C
Biochim Biophys Acta; 2002 Jul; 1587(2-3):287-95. PubMed ID: 12084470
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and anti-HSV-1 evaluation of some pyrazoles and fused pyrazolopyrimidines.
Rashad AE; Hegab MI; Abdel-Megeid RE; Fathalla N; Abdel-Megeid FM
Eur J Med Chem; 2009 Aug; 44(8):3285-92. PubMed ID: 19285757
[TBL] [Abstract][Full Text] [Related]
35. Mutations distal to the substrate site can affect varicella zoster virus thymidine kinase activity: implications for drug design.
El Omari K; Liekens S; Bird LE; Balzarini J; Stammers DK
Mol Pharmacol; 2006 Jun; 69(6):1891-6. PubMed ID: 16556772
[TBL] [Abstract][Full Text] [Related]
36. N1-substituted thymine derivatives as mitochondrial thymidine kinase (TK-2) inhibitors.
Hernandez AI; Familiar O; Negri A; Rodríguez-Barrios F; Gago F; Karlsson A; Camarasa MJ; Balzarini J; Pérez-Pérez MJ
J Med Chem; 2006 Dec; 49(26):7766-73. PubMed ID: 17181158
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antiviral screening of some thieno[2,3-d]pyrimidine nucleosides.
Rashad AE; Ali MA
Nucleosides Nucleotides Nucleic Acids; 2006; 25(1):17-28. PubMed ID: 16440982
[TBL] [Abstract][Full Text] [Related]
38. 5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
Spadari S; Ciarrocchi G; Focher F; Verri A; Maga G; Arcamone F; Iafrate E; Manzini S; Garbesi A; Tondelli L
Mol Pharmacol; 1995 Jun; 47(6):1231-8. PubMed ID: 7603465
[TBL] [Abstract][Full Text] [Related]
39. The synthesis and some properties of some 5-substituted pyrimidine 4'-thio-2'-deoxynucleosides and oligodeoxynucleotides containing 4'-thiothymidine.
Basnak I; Hancox EL; Connolly BA; Walker RT
Nucleic Acids Symp Ser; 1993; (29):101-2. PubMed ID: 8247724
[TBL] [Abstract][Full Text] [Related]
40. Understanding the binding of 5-substituted 2'-deoxyuridine substrates to thymidine kinase of herpes simplex virus type-1.
De Winter H; Herdewijn P
J Med Chem; 1996 Nov; 39(24):4727-37. PubMed ID: 8941385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
